Jupiter Investment Management’s Gilead Sciences GILD Stock Holding History

Jupiter Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$301K	Buy	3,923 +600	+18%	+$46K	﹤0.01%	356
2020 Q1	$248K	Sell	3,323 -347,500	-99%	-$24M	﹤0.01%	333
2019 Q4	$22.8M	Hold	350,823	–	–	0.32%	99
2019 Q3	$22.2M	Buy	350,823 +241,657	+221%	+$15.8M	0.29%	105
2019 Q2	$7.38M	Sell	109,166 -425,212	-80%	-$28M	0.08%	176
2019 Q1	$34.7M	Buy	534,378 +60,038	+13%	+$3.99M	0.32%	91
2018 Q4	$29.7M	Buy	474,340 +390,744	+467%	+$27.3M	0.26%	95
2018 Q3	$6.45M	Buy	+83,596	New	+$6.31M	0.04%	176
2018 Q2	–	Sell	-44,337	Closed	-$3.34M	–	402
2018 Q1	$3.34M	Buy	44,337 +27,518	+164%	+$2.19M	0.03%	213
2017 Q4	$1.2M	Sell	16,819 -507,689	-97%	-$38.6M	0.01%	242
2017 Q3	$42.5M	Buy	524,508 +264,320	+102%	+$20.2M	0.44%	76
2017 Q2	$18.4M	Buy	260,188 +147,911	+132%	+$9.84M	0.22%	110
2017 Q1	$7.63M	Sell	112,277 -406,692	-78%	-$28.6M	0.11%	131
2016 Q4	$37.2M	Sell	518,969 -1,062,116	-67%	-$78.9M	0.64%	53
2016 Q3	$125M	Buy	1,581,085 +424,462	+37%	+$34.5M	2.17%	5
2016 Q2	$96.5M	Buy	1,156,623 +832,028	+256%	+$73.8M	1.81%	8
2016 Q1	$29.8M	Sell	324,595 -598,450	-65%	-$54M	0.61%	57
2015 Q4	$93.4M	Buy	923,045 +19,064	+2%	+$1.98M	2.49%	4
2015 Q3	$88.8M	Buy	903,981 +197,329	+28%	+$21.9M	2.51%	3
2015 Q2	$82.7M	Buy	706,652 +391,655	+124%	+$42.8M	2.41%	2
2015 Q1	$30.9M	Sell	314,997 -257,902	-45%	-$26.2M	0.98%	40
2014 Q4	$54M	Buy	572,899 +511,476	+833%	+$52.9M	1.91%	5
2014 Q3	$6.54M	Sell	61,423 -104,264	-63%	-$10.2M	0.32%	87
2014 Q2	$13.7M	Sell	165,687 -182,319	-52%	-$14.2M	0.77%	44
2014 Q1	$24.7M	Buy	348,006 +69,530	+25%	+$5.45M	1.67%	2
2013 Q4	$20.9M	Buy	278,476 +93,730	+51%	+$6.53M	1.76%	1
2013 Q3	$11.6M	Buy	184,746 +89,428	+94%	+$5.34M	1.1%	15
2013 Q2	$4.88M	Buy	+95,318	New	+$4.97M	0.59%	62

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Jupiter Investment Management's GILD Position: Q2 2020 in Review

Jupiter Investment Management increased its Gilead Sciences (GILD) stake by 18% in Q2 2020, buying an estimated $46K and bringing the position to 3,923 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

Jupiter Investment Management first reported a position in GILD in Q2 2013 and has held it in 28 quarters since. The position peaked at $125M in Q3 2016. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Jupiter Investment Management held 3,923 shares of Gilead Sciences worth $301K as of Q2 2020.
Jupiter Investment Management bought 600 Gilead Sciences shares in Q2 2020, an estimated $46K.
Gilead Sciences made up ﹤0.01% of Jupiter Investment Management's portfolio in Q2 2020, its #356 holding.
Jupiter Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 28 quarters since.
Jupiter Investment Management's Gilead Sciences position peaked at $125M in Q3 2016.
1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.